Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Hospital Medicine
•
General Hospital Medicine
What O2 saturation goal do you target when managing COPD exacerbations, considering conflicting guidelines with some recommending 88-92% and others >90%?
Related Questions
How do you decide which IV opioid to use for symptom relief at the end of life?
How do you decide whether to use pharmacologic VTE prophylaxis in hospitalized patients with decompensated cirrhosis?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
What is your approach to volume resuscitation in patients who are third spacing fluids?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
Do you routinely use systemic corticosteroids for treatment of fat embolism in patients who are hemodynamically stable?
Do you always stop dexamethasone at discharge for patients admitted with COVID requiring respiratory support (as done in the RECOVERY trial), or are there situations in which you will prescribe it to complete a 10-day course?
Do you ever consider sodium supplementation to augment diuresis in patients hospitalized with decompensated heart failure, as discussed in a recent systematic review and meta-analysis?
What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?
When do you consider a trial of steroids for acute hypoxemic respiratory failure when there are no other clear indications for its use (i.e., COVID, COPD, organizing pneumonia, etc.)?